{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:33:01Z","timestamp":1793089981010,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1097\/aog.0000000000000620","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T13:32:53Z","timestamp":1420723973000},"page":"477-486","source":"Crossref","is-referenced-by-count":86,"title":["Female Sexual Dysfunction"],"prefix":"10.1097","volume":"125","author":[{"given":"Sheryl A.","family":"Kingsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Woodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20210126","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors.","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"key":"R2-29-20210126","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: prevalence and correlates.","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R5-29-20210126","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/GME.0000000000000131","article-title":"Hypoactive sexual desire in women.","volume":"20","author":"Kingsberg","year":"2013","journal-title":"Menopause"},{"key":"R6-29-20210126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.gme.0000172596.76272.06","article-title":"Hypoactive sexual desire disorder in postmenopausal women: US results from the Womens International Study of Health and Sexuality (WISHeS).","volume":"13","author":"Leiblum","year":"2006","journal-title":"Menopause"},{"key":"R7-29-20210126","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1524-4733.2008.00483.x","article-title":"Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden.","volume":"12","author":"Biddle","year":"2009","journal-title":"Value Health"},{"key":"R8-29-20210126","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00926230152035831","article-title":"Human sex-response cycles.","volume":"27","author":"Basson","year":"2001","journal-title":"J Sex Marital Ther"},{"key":"R9-29-20210126","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1111\/j.1743-6109.2010.01899.x","article-title":"Response of the DSM-V Sexual Dysfunctions subworkgroup to commentaries published in JSM.","volume":"7","author":"Binik","year":"2010","journal-title":"J Sex Med"},{"key":"R10-29-20210126","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00926230600666261","article-title":"The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): psychometric properties within a Dutch population.","volume":"32","author":"ter Kuile","year":"2006","journal-title":"J Sex Marital Ther"},{"key":"R11-29-20210126","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.168.13.1441","article-title":"Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.","volume":"168","author":"West","year":"2008","journal-title":"Arch Intern Med"},{"key":"R12-29-20210126","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/jwh.2011.3002","article-title":". Sexual desire problems in women seeking healthcare: a novel study design for ascertaining prevalence of hypoactive sexual desire disorder in clinic-based samples of U.S. women.","volume":"21","author":"Rosen","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"key":"R13-29-20210126","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.847460","article-title":"The need for a new medical model: a challenge for biomedicine.","volume":"196","author":"Engel","year":"1977","journal-title":"Science"},{"key":"R14-29-20210126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(07)60197-4","article-title":"Sexual sequelae of general medical disorders.","volume":"369","author":"Basson","year":"2007","journal-title":"Lancet"},{"key":"R15-29-20210126","first-page":"33","article-title":"Medications that may contribute to sexual disorders. A guide to assessment and treatment in family practice.","volume":"44","author":"Finger","year":"1997","journal-title":"J Fam Pract"},{"key":"R16-29-20210126","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/gme.0b013e31815a5168","article-title":"Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women.","volume":"15","author":"Levine","year":"2008","journal-title":"Menopause"},{"key":"R17-29-20210126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/13697139909038085","article-title":"Factors affecting sexual functioning of women in the mid-life years.","volume":"2","author":"Dennerstein","year":"1999","journal-title":"Climacteric"},{"key":"R18-29-20210126","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1743-6109.2009.01630.x","article-title":"Womens sexual desire and arousal disorders.","volume":"7","author":"Brotto","year":"2010","journal-title":"J Sex Med"},{"key":"R19-29-20210126","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1743-6109.2009.01222.x","article-title":". Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily.","volume":"6","author":"Rubio-Aurioles","year":"2009","journal-title":"J Sex Med"},{"key":"R20-29-20210126","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1743-6109.2010.01731.x","article-title":"The HSDD registry for women: a novel patient registry for women with generalized acquired hypoactive sexual desire disorder.","volume":"7","author":"Rosen","year":"2010","journal-title":"J Sex Med"},{"key":"R21-29-20210126","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/jwh.2008.1133","article-title":"Help-seeking behavior of women with self-reported distressing sexual problems.","volume":"18","author":"Shifren","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"R22-29-20210126","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0015-0282(02)04695-2","article-title":". Seeking help for sexual function complaints: what gynecologists need to know about the female patients experience.","volume":"79","author":"Berman","year":"2003","journal-title":"Fertil Steril"},{"key":"R23-29-20210126","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.fertnstert.2013.08.026","article-title":"Managing female sexual dysfunction.","volume":"100","author":"Buster","year":"2013","journal-title":"Fertil Steril"},{"key":"R24-29-20210126","first-page":"252","article-title":"Mid-to-late-life women and sexual health: communication with health care providers.","volume":"45","author":"Hughes","year":"2013","journal-title":"Fam Med"},{"key":"R25-29-20210126","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1743-6109.2008.01153.x","article-title":"Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD).","volume":"6","author":"Clayton","year":"2009","journal-title":"J Sex Med"},{"key":"R26-29-20210126","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/j.1743-6109.2010.01742.x","article-title":"Prevalence of sexual dysfunction and impact of contraception in female German medical students.","volume":"7","author":"Wallwiener","year":"2010","journal-title":"J Sex Med"},{"key":"R27-29-20210126","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1024\/0369-8394.92.25.1177","article-title":"Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin) in German.","volume":"92","author":"Bitzer","year":"2003","journal-title":"Praxis (Bern 1)"},{"key":"R28-29-20210126","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1743-6109.2012.02848.x","article-title":"The effects of hormonal contraceptives on female sexuality: a review.","volume":"9","author":"Burrows","year":"2012","journal-title":"J Sex Med"},{"key":"R29-29-20210126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13625187.2012.728643","article-title":"The influence of combined oral contraceptives on female sexual desire: a systematic review.","volume":"18","author":"Pastor","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R30-29-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1743-6109.2012.02823.x","article-title":"Standard operating procedures for taking a sexual history.","volume":"10","author":"Althof","year":"2013","journal-title":"J Sex Med"},{"key":"R31-29-20210126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jama.294.1.91","article-title":"Circulating androgen levels and self-reported sexual function in women.","volume":"294","author":"Davis","year":"2005","journal-title":"JAMA"},{"key":"R32-29-20210126","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1210\/jc.2004-2063","article-title":". Correlates of circulating androgens in mid-life women: the study of womens health across the nation.","volume":"90","author":"Santoro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"R33-29-20210126","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00926230252851258","article-title":"Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido.","volume":"28","author":"Guay","year":"2002","journal-title":"J Sex Marital Ther"},{"issue":"suppl 1","key":"R34-29-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00926230252851348","article-title":"Epidemiological characteristics of 250 women with sexual dysfunction who presented for initial evaluation.","volume":"28","author":"Talakoub","year":"2002","journal-title":"J Sex Marital Ther"},{"key":"R36-29-20210126","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14681990120040078","article-title":"The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women.","volume":"16","author":"Trudela","year":"2001","journal-title":"Sex Relat Ther"},{"key":"R37-29-20210126","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0005-7967(86)90062-8","article-title":"Long-term outcome of sex therapy.","volume":"24","author":"Hawton","year":"1986","journal-title":"Behav Res Ther"},{"key":"R38-29-20210126","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1743-6109.2008.00850.x","article-title":"A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women.","volume":"5","author":"Brotto","year":"2008","journal-title":"J Sex Med"},{"key":"R39-29-20210126","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1111\/j.1743-6109.2012.02965.x","article-title":"Efficacy of psychosocial interventions in men and women with sexual dysfunctionsa systematic review of controlled clinical trials: part 2the efficacy of psychosocial interventions for female sexual dysfunction.","volume":"9","author":"Gunzler","year":"2012","journal-title":"J Sex Med"},{"key":"R41-29-20210126","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2012.01.035","article-title":". A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer.","volume":"125","author":"Brotto","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R42-29-20210126","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jsm.12377","article-title":"The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: a systematic review and meta-analysis.","volume":"11","author":"Cui","year":"2014","journal-title":"J Sex Med"},{"key":"R43-29-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/13697137.2013.834493","article-title":". Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.","volume":"17","author":"Goldstein","year":"2014","journal-title":"Climacteric"},{"key":"R44-29-20210126","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1743-6109.2011.02634.x","article-title":"Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.","volume":"9","author":"Davis","year":"2012","journal-title":"J Sex Med"},{"key":"R45-29-20210126","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/j.1743-6109.2009.01294.x","article-title":"Approved hormonal treatments for HSDD: an unmet medical need.","volume":"6","author":"Snabes","year":"2009","journal-title":"J Sex Med"},{"key":"R47-29-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2007.01.118","article-title":"Safety of testosterone treatment in postmenopausal women.","volume":"88","author":"Braunstein","year":"2007","journal-title":"Fertil Steril"},{"key":"R48-29-20210126","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa0707302","article-title":". Testosterone for low libido in postmenopausal women not taking estrogen.","volume":"359","author":"Davis","year":"2008","journal-title":"N Engl J Med"},{"key":"R49-29-20210126","first-page":"996","article-title":"Practice Bulletin No. 119. American College of Obstetricians and Gynecologists.","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R50-29-20210126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/09513590.2010.487597","article-title":"Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.","volume":"27","author":"Nachtigall","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"R51-29-20210126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ijir.2009.64","article-title":"Testosterone, SHBG and cardiovascular health in postmenopausal women.","volume":"22","author":"Brand","year":"2010","journal-title":"Int J Impot Res"},{"key":"R52-29-20210126","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1210\/jc.2009-1693","article-title":"Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women.","volume":"95","author":"Laughlin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-29-20210126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MED.0b013e328344f449","article-title":"Cardiovascular and cancer safety of testosterone in women.","volume":"18","author":"Davis","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R54-29-20210126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinternmed.2008.507","article-title":"Influence of estrogen plus testosterone supplementation on breast cancer.","volume":"169","author":"Ness","year":"2009","journal-title":"Arch Intern Med"},{"key":"R55-29-20210126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2011.09.021","article-title":"A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.","volume":"163","author":"White","year":"2012","journal-title":"Am Heart J"},{"key":"R56-29-20210126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/009262301750257155","article-title":". Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women.","volume":"27","author":"Segraves","year":"2001","journal-title":"J Sex Marital Ther"},{"key":"R57-29-20210126","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1464-410X.2010.09208.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women.","volume":"106","author":"Safarinejad","year":"2010","journal-title":"BJU Int"},{"key":"R58-29-20210126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0269881109351966","article-title":"Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.","volume":"25","author":"Safarinejad","year":"2011","journal-title":"J Psychopharmacol"},{"key":"R59-29-20210126","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1743-6109.2012.02983.x","article-title":". Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.","volume":"10","author":"Poels","year":"2013","journal-title":"J Sex Med"},{"key":"R60-29-20210126","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1743-6109.2012.02982.x","article-title":". Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.","volume":"10","author":"van Rooij","year":"2013","journal-title":"J Sex Med"},{"issue":"suppl 1","key":"R61-29-20210126","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1097\/01.AOG.0000447299.24824.6b","article-title":"Bremelanotide for hypoactive sexual desire disorder: analyses from a phase 2B dose-ranging study.","volume":"123","author":"Portman","year":"2014","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:20:09Z","timestamp":1620944409000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201502000-00029"}},"subtitle":["Focus on Low Desire"],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000620","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}